We sit down with three distinguished endocrinologists—Dr. Kashif Latif, Dr. Michael James Haller, and Dr. Kevin Kaiserman—to discuss the last 100 years of innovation in diabetes treatment, from starvation diets to modern insulin therapy. In this episode, we discuss FDA and non-FDA-approved interventions in medical science. Please do not rely on this podcast for medical advice or as a guide for prescribing. The following were mentioned on the podcast, and you should be aware of their side effects and complete indications as prescribed by the FDA.
As with any treatment, it’s important to understand the potential adverse reactions with TZIELD. Throughout the TN-10 Study, greater incidences of cytokine release syndrome, serious infections, hypersensitivity reactions, and serum sickness, lymphopenia, and neutropenia were reported in TZIELD-treated patients vs placebo-treated patients. Most common adverse reactions (>10%) were lymphopenia, rash, leukopenia, and headache. These are not all the adverse reactions reported with TZIELD. Please see full Important Safety Information and Prescribing Information.
AFREZZA can cause serious side effects, including: Sudden lung problems (bronchospasms). In a study, some AFREZZA-treated patients with asthma, whose asthma medication was temporarily withheld, experienced sudden lung problems. Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting AFREZZA, consult your healthcare clinician.
01:25 Early Screening and Universal Screening
02:18 Dr. Latif's Journey into Endocrinology
04:22 Dr. Haller's Path to Pediatric Endocrinology
05:09 Dr. Kaiserman's Career in Diabetes Care
05:54 The Importance of EHR in Diabetes Management
08:21 Project ECHO: Extending Community Health Outcomes
15:39 The Evolution of Insulin Therapy
24:22 Revolutionizing Diabetes Care with Inhaled Insulin
28:19 Refrigeration and Stability of Insulin
28:43 Human Insulin and Genetic Engineering
30:04 Inhaled Insulin vs. Insulin Pumps
31:33 Inhaled Insulin for Type 2 Diabetics
32:28 Challenges in Managing Type 1 Diabetes
36:23 Preventing and Delaying Insulin Dependency
38:53 The Importance of Early Screening
50:14 Future of Type 1 Diabetes Treatment
🔴 Subscribe for more Doctor stories like this: 🎧Apple and give us a 5-star review.
Read more on the TPL Website
SOCIAL Media Pages ===============================
📝 - Substack
🎧 - PODCAST
👥 - FACEBOOK
🐦 - TWITTER
📸 - Instagram
➡️ - Linkedin
The Pediatric Lounge - A Podcast taking you behind the door of the Physician's Lounge to get a deeper insight into what docs are talking about today, from the clinically profound to the wonderfully routine...and everything in between.
The conversations are not intended as medical advice, and the opinions expressed are solely those of the host and guest.